Ventyx Biosciences Inc Financial Flexibility Index
Ventyx Biosciences Inc financial flexibility index. Ventyx Biosciences Inc (VTYX) has a Financial Flexibility Index of -0.87x as of September 2025. Free cash flow of $-17.46 Million (operating CF $-17.51 Million minus capex $50.00K) represents -1% of total liabilities ($20.10 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ventyx Biosciences Inc (2019–2024)
Financial flexibility index of Ventyx Biosciences Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Ventyx Biosciences Inc across 6 annual periods. Explore VTYX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Ventyx Biosciences Inc Financial Flexibility Index by Year (2019–2024)
Ventyx Biosciences Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Ventyx Biosciences Inc. For the full cash flow conversion analysis, see Ventyx Biosciences Inc (VTYX) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.80x | $-130.63 Million | $-130.87 Million | $22.52 Million | ▼ -18.0% |
| 2023 | -4.92x | $-166.01 Million | $-166.52 Million | $33.77 Million | ▲ +12.6% |
| 2022 | -5.63x | $-98.50 Million | $-98.77 Million | $17.50 Million | ▼ -80.0% |
| 2021 | -3.13x | $-38.39 Million | $-38.65 Million | $12.28 Million | ▼ -1527.7% |
| 2020 | -0.19x | $-5.93 Million | $-6.20 Million | $30.90 Million | ▲ +63.9% |
| 2019 | -0.53x | $-2.38 Million | $-2.64 Million | $4.48 Million | — |